San Francisco
Benchling is a biotechnology company and developer of a platform that allows researchers to design and run experiments, analyze data, and share results.
Estimated valuation today
$320M
-94.75% since last round
Calculated based on estimated multiplier and revenue.
Revenue
Update this based on your knowledge or projections. Calculations use last 12 months revenue.
Hype Multiple
Currently selected comps have a median growth rate of 11.40%
This premium represents how much of a bonus the company receives on its valuation for its additional growth compared to the selected public comps. The valuation is multipled by the Hype Multiple to get the final valuation. You can read more about this from a16z.
multiple
In an event of a merger or aquisition, the investors will get their money back first. In this case, the investors got paid out first and there is no money left which means employee common stock is worthless.
The last round was 10 months ago.
Date
October 2021
Valuation
$6.1B
Amount raised
$11M
We estimate company valuation by comparing it to similiar companies in the public market. The revenue multipler is calculated by taking a company's current valuation and dividing it by its total revenue.
Multiple at last round
1.61x revenue
Today's multiple
1.64x revenue
Change
1.63%
Companies
Industry – Healthcare
Last updated 5 mins ago.
| Remove | Name | Ticker | Price multiple |
|---|---|---|---|
| Benchling | 1.64x | ||
| 1Life Healthcare Inc | ONEM | 4.38x | |
| HCA Holdings Inc | HCA | 1.04x | |
| Tenet Healthcare Corporation | THC | 0.37x | |
| Quest Diagnostics Incorporated | DGX | 1.51x | |
| Humana Inc | HUM | 0.67x |
| Date | Round | Amount raised | Price per share (Preferred) | Valuation |
|---|---|---|---|---|
| Oct 2021 | Series F-1 | $11MM | $32.70 | $6.1B |
| Oct 2021 | Series F | $95MM | $32.70 | $6.1B |
| Apr 2021 | Series E | $200MM | $23.22 | $4.17B |
| May 2020 | Series D | $50.55MM | $5.56 | $889.2MM |
| Jul 2019 | Series C | $37.03MM | $2.85 | $409.65MM |
| Jun 2018 | Series B | $18.25MM | $0.64 | $85.05MM |
| Oct 2016 | Series A | $7MM | $0.45 | $37.94MM |
| Apr 2015 | Series Seed | $6.14MM | $0.28 | $17.54MM |
With a revenue of $130M and a Hype Multiple of 1.5x,
Benchling is estimated to be worth $320M.